| Prevention | |
- Counsel all diabetic women of childbearing potential on the need for pregnancy planning.
- Counsel all obese women of childbearing age on the need for diet and exercise to decrease the risk of gestational diabetes.
- Stop ACE inhibitor therapy, switch oral hypoglycemics to insulin, and review all other medications before conception.
|
| 
Counsel all diabetic women of childbearing potential on the need for pregnancy planning.  |
- Ensure effective birth control at all times, unless the patient is trying to conceive and is in good diabetic control.
- Counsel women with type 1 or 2 diabetes on the risks of fetal malformation associated with unplanned pregnancies and poor metabolic control.
- Achieve fasting whole-blood glucose levels of 70 to 100 mg/dL and 2-hour postprandial levels of <140 mg/dL in diabetic women planning pregnancies.
| Background | Back to top
|
Counsel all obese women of childbearing age on the need for diet and exercise to decrease the risk of gestational diabetes.  |
- Provide nutritional counseling to obese women of childbearing age consistent with American Diabetes Association recommendations.
- Consider recommending to obese women planning pregnancy or already pregnant:
- A 30% to 33% calorie restriction if BMI >30
- Limiting fat intake to <30% of calories
- Increasing physical activity, as recommended outside pregnancy, or a program of moderate exercise if the woman is already pregnant
| Background | Back to top
|
Stop ACE inhibitor therapy, switch oral hypoglycemics to insulin, and review all other medications before conception. |
- Stop all ACE-inhibitors and angiotensin-receptor blockers.
- Switch oral hypoglycemic agents to insulin therapy.
- Stop cholesterol-lowering drugs.
- Stop aspirin therapy.
- Review other medications and stop any potential teratogens.
| Background | Back to top
| | | FAQs |
|
|
Elisha L. Brownfield, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Justin B. Moore, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
Diabetes in Pregnancy
